Clinical Trial Update: A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for LY3316531 in healthy participants and psoriasis patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• LY3316531

Snippet

Sponsor: Eli Lilly and Company | Conditions: Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2023-09-21